These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31592604)

  • 1. Alternative biomarkers for immunotherapy.
    Hellevik T; Martinez-Zubiaurre I
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592604
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular imaging biomarkers for immune checkpoint inhibitor therapy.
    van de Donk PP; Kist de Ruijter L; Lub-de Hooge MN; Brouwers AH; van der Wekken AJ; Oosting SF; Fehrmann RS; de Groot DJA; de Vries EG
    Theranostics; 2020; 10(4):1708-1718. PubMed ID: 32042331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond haematuria in uro oncology: imaging biomarkers lag behind needs.
    Lucignani G
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):152-7. PubMed ID: 19005654
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular imaging to enlighten cancer immunotherapies and underlying involved processes.
    van der Veen EL; Bensch F; Glaudemans AWJM; Lub-de Hooge MN; de Vries EGE
    Cancer Treat Rev; 2018 Nov; 70():232-244. PubMed ID: 30308466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating molecular nuclear imaging in clinical research to improve anticancer therapy.
    de Vries EGE; Kist de Ruijter L; Lub-de Hooge MN; Dierckx RA; Elias SG; Oosting SF
    Nat Rev Clin Oncol; 2019 Apr; 16(4):241-255. PubMed ID: 30479378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Responses to Immunotherapy with Novel PET Tracers.
    Niemeijer AL; Hoekstra OS; Smit EF; de Langen AJ
    J Nucl Med; 2020 May; 61(5):641-642. PubMed ID: 32086241
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular Imaging of Immunotherapy Targets in Cancer.
    Ehlerding EB; England CG; McNeel DG; Cai W
    J Nucl Med; 2016 Oct; 57(10):1487-1492. PubMed ID: 27469363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.
    Pantel AR; Mankoff DA
    Cancer Lett; 2017 Feb; 387():25-31. PubMed ID: 27195912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of molecular imaging technology in tumor immunotherapy.
    Meng Y; Sun J; Qv N; Zhang G; Yu T; Piao H
    Cell Immunol; 2020 Feb; 348():104039. PubMed ID: 32007223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal tumor models for PET in drug development.
    Toyohara J; Ishiwata K
    Ann Nucl Med; 2011 Dec; 25(10):717-31. PubMed ID: 21879295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
    Jørgensen JT; Persson M; Madsen J; Kjær A
    Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled glucose derivatives for tumor imaging using SPECT and PET.
    Liu T; Zhang J; Wang X; Yang J; Tang Z; Lu J
    Curr Med Chem; 2014; 21(1):24-34. PubMed ID: 23992343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncology.
    Larson SM
    J Nucl Med; 2011 Nov; 52(11):13N-20N. PubMed ID: 22045711
    [No Abstract]   [Full Text] [Related]  

  • 14. ImmunoPET to help stratify patients for targeted therapies and to improve drug development.
    Kraeber-Bodere F; Bailly C; Chérel M; Chatal JF
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2166-2168. PubMed ID: 27539021
    [No Abstract]   [Full Text] [Related]  

  • 15. PET imaging to monitor cancer therapy.
    Malviya G; Nayak TK
    Curr Pharm Biotechnol; 2013; 14(7):669-82. PubMed ID: 24372238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: do we need additional tracers for clinical purposes?
    Kwee TC; Gholami S; Werner TJ; Rubello D; Alavi A; Høilund-Carlsen PF
    Nucl Med Commun; 2016 Apr; 37(4):333-7. PubMed ID: 26796033
    [No Abstract]   [Full Text] [Related]  

  • 17. PET of signal transduction pathways in cancer.
    Holland JP; Cumming P; Vasdev N
    J Nucl Med; 2012 Sep; 53(9):1333-6. PubMed ID: 22879078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid transporter-targeted radiotracers for molecular imaging in oncology.
    Kong FL; Yang DJ
    Curr Med Chem; 2012; 19(20):3271-81. PubMed ID: 22664245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond 18F-fluorodeoxyglucose: making the next generation of PET radiotracers available for oncology research in the UK.
    Gilbert FJ; Fleming IN; Marsden PK
    Nucl Med Commun; 2011 Jan; 32(1):1-3. PubMed ID: 21119502
    [No Abstract]   [Full Text] [Related]  

  • 20. PET beyond ¹⁸F-FDG: second generation PET tracers in clinical oncology.
    Brouwers AH; Glaudemans AW; De Vries EF
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):1-3. PubMed ID: 25854554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.